BioCentury | Apr 14, 2014
Clinical News

Piccolo Xpress regulatory update

...The reclassification allows for point-of-care diagnostic use instead of for use in a laboratory environment. Abaxis...
...not affect the price of the analyzer. The company does not break out Canadian revenues. Abaxis Inc....
BioCentury | Sep 30, 2013
Company News

Abaxis management update

...chief commercial officer, effective Oct. 4; COO Don Wood will assume Mulroy's responsibilities for leading Abaxis'...
BioCentury | Dec 17, 2012
Financial News

Abaxis financial update

...Dec. 17. The company, which closed at $36.74 on Friday, has 22 million shares outstanding. Abaxis Inc....
BioCentury | Oct 1, 2012
Company News

Abaxis, Cepheid diagnostic news

...Patent Nos. 5,413,732; 5,624,597; 5,776,563; and 6,251,684 relating to reagent and chemical compositions and processes. Abaxis...
...first patent expiration was in May 2012, while the last patent expiration is in 2015. Abaxis...
...of Abaxis' IP which included the '732, '597, '563 and '684 patents. Under the settlement, Abaxis...
BioCentury | Jan 25, 2010
Clinical News

C-Reactive Protein assay regulatory update

...FDA granted 510(k) clearance for Abaxis' C-Reactive Protein (CRP) assay to detect inflammation or infection. Abaxis...
...by rheumatologists to detect rheumatoid arthritis. The company plans to launch the assay this quarter. Abaxis Inc....
BioCentury | Sep 28, 2009
Politics, Policy & Law

The Counterattack

...pipeline of new therapies and technologies being developed. The letter was signed by CEOs of Abaxis Inc....
...the very different bill that the House is likely to pass. Companies and Institutions Mentioned Abaxis Inc....
BioCentury | Sep 24, 2009
Politics & Policy

BayBio lobbying against PhRMA tax

...technologies being developed." The letter was signed by CEOs of 15 California biomedical companies, including: Abaxis Inc....
BioCentury | Dec 22, 2008
Clinical News

Piccolo Xpress regulatory update

...creatine kinase when used in conjunction with Abaxis' Piccolo or Piccolo Xpress point-of-care blood tests. Abaxis Inc....
BioCentury | Nov 3, 2008
Finance

Ebb & Flow

...founder and CEO of John Halsey; BKD partner Steven Mock; Trinity shareholder Thomas Reidy and Abaxis...
BioCentury | Dec 4, 2006
Company News

CytoCore board of directors update

CytoCore Inc. (CYCR), Chicago, Ill. Business: Diagnostic Appointed: Clint Severson, CEO of Abaxis Inc. WIR Staff Diagnostic...
Items per page:
1 - 10 of 30
BioCentury | Apr 14, 2014
Clinical News

Piccolo Xpress regulatory update

...The reclassification allows for point-of-care diagnostic use instead of for use in a laboratory environment. Abaxis...
...not affect the price of the analyzer. The company does not break out Canadian revenues. Abaxis Inc....
BioCentury | Sep 30, 2013
Company News

Abaxis management update

...chief commercial officer, effective Oct. 4; COO Don Wood will assume Mulroy's responsibilities for leading Abaxis'...
BioCentury | Dec 17, 2012
Financial News

Abaxis financial update

...Dec. 17. The company, which closed at $36.74 on Friday, has 22 million shares outstanding. Abaxis Inc....
BioCentury | Oct 1, 2012
Company News

Abaxis, Cepheid diagnostic news

...Patent Nos. 5,413,732; 5,624,597; 5,776,563; and 6,251,684 relating to reagent and chemical compositions and processes. Abaxis...
...first patent expiration was in May 2012, while the last patent expiration is in 2015. Abaxis...
...of Abaxis' IP which included the '732, '597, '563 and '684 patents. Under the settlement, Abaxis...
BioCentury | Jan 25, 2010
Clinical News

C-Reactive Protein assay regulatory update

...FDA granted 510(k) clearance for Abaxis' C-Reactive Protein (CRP) assay to detect inflammation or infection. Abaxis...
...by rheumatologists to detect rheumatoid arthritis. The company plans to launch the assay this quarter. Abaxis Inc....
BioCentury | Sep 28, 2009
Politics, Policy & Law

The Counterattack

...pipeline of new therapies and technologies being developed. The letter was signed by CEOs of Abaxis Inc....
...the very different bill that the House is likely to pass. Companies and Institutions Mentioned Abaxis Inc....
BioCentury | Sep 24, 2009
Politics & Policy

BayBio lobbying against PhRMA tax

...technologies being developed." The letter was signed by CEOs of 15 California biomedical companies, including: Abaxis Inc....
BioCentury | Dec 22, 2008
Clinical News

Piccolo Xpress regulatory update

...creatine kinase when used in conjunction with Abaxis' Piccolo or Piccolo Xpress point-of-care blood tests. Abaxis Inc....
BioCentury | Nov 3, 2008
Finance

Ebb & Flow

...founder and CEO of John Halsey; BKD partner Steven Mock; Trinity shareholder Thomas Reidy and Abaxis...
BioCentury | Dec 4, 2006
Company News

CytoCore board of directors update

CytoCore Inc. (CYCR), Chicago, Ill. Business: Diagnostic Appointed: Clint Severson, CEO of Abaxis Inc. WIR Staff Diagnostic...
Items per page:
1 - 10 of 30